Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA
Akston has reclaimed all commercial rights to AKS-452, its room temperature stable COVID-19 vaccine Akston is continuing its progress to secure Emergency Use Authorization (EUA) in India and has begun working with a new CDMO to produce AKS-452 Akston Bioscienc